hereditary kidney diseasechronic kidney diseasepaediatric CKDdapagliflozinRAASiNCT06890143Sodium-glucose cotransporter-2 inhibitors
…sover, open-label clinical trial. Patients aged 6–18 years with hereditary kidney disease will be eligible. All patients must have received stable RAASi …